Krebs Biochemicals & Industries Limited (KREBSBIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 857.45M |
| Enterprise Value | 3.1B |
| P/E Ratio | -8.79 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 4.91 |
| Price/Book Ratio | -0.76 |
| Enterprise/Revenue | 4.91 |
| Enterprise/EBITDA | -237.64 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.56 |
| Operating Margin | -0.35 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 237.32M |
| Revenue/Share | 11.7 |
| Gross Profit | 65.3M |
| EBITDA | -34.24M |
| Net Income | -169.33M |
| Diluted EPS | -7.85 |
Balance Sheet
| Total Cash | 1.29M |
| Total Cash/Share | 0 |
| Total Debt | 2.25B |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | -75.49 |
Price History
| 52-Week Change | -17.08 |
| 52-Week High | 76.85 |
| 52-Week Low | 38.33 |
| Moving Average 50 Days | 57.36 |
| Moving Average 200 Days | 57.91 |
Statistics
| Average Volume | 24,763 |
| Shares Outstanding | 21.56M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 207:200 |
| Last Split Date | January 31, 2019 |
AD
